These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1233 related items for PubMed ID: 18583169

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, Ramió-Torrentà L, Graus F.
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [Abstract] [Full Text] [Related]

  • 3. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity.
    Saiz A, Arpa J, Sagasta A, Casamitjana R, Zarranz JJ, Tolosa E, Graus F.
    Neurology; 1997 Oct; 49(4):1026-30. PubMed ID: 9339684
    [Abstract] [Full Text] [Related]

  • 4. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients.
    Honnorat J, Saiz A, Giometto B, Vincent A, Brieva L, de Andres C, Maestre J, Fabien N, Vighetto A, Casamitjana R, Thivolet C, Tavolato B, Antoine J, Trouillas P, Graus F.
    Arch Neurol; 2001 Feb; 58(2):225-30. PubMed ID: 11176960
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Steroid treatment in four cases of anti-GAD cerebellar ataxia].
    Bonnan M, Cabre P, Olindo S, Signate A, Saint-Vil M, Smadja D.
    Rev Neurol (Paris); 2008 May; 164(5):427-33. PubMed ID: 18555874
    [Abstract] [Full Text] [Related]

  • 7. [A new case of cerebellar ataxia with anti-GAD antibodies treated with corticosteroids and initially seronegative].
    Birand B, Cabre P, Bonnan M, Olindo S, Smadja D.
    Rev Med Interne; 2006 Aug; 27(8):616-9. PubMed ID: 16797794
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M, Tavolato B, Giometto B.
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [Abstract] [Full Text] [Related]

  • 10. Opsoclonus-myoclonus-ataxia syndrome with autoantibodies to glutamic acid decarboxylase.
    Markakis I, Alexiou E, Xifaras M, Gekas G, Rombos A.
    Clin Neurol Neurosurg; 2008 Jun; 110(6):619-21. PubMed ID: 18433986
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Spontaneous downbeat nystagmus as a clue for the diagnosis of ataxia associated with anti-GAD antibodies.
    Vale TC, Pedroso JL, Alquéres RA, Dutra LA, Barsottini OG.
    J Neurol Sci; 2015 Dec 15; 359(1-2):21-3. PubMed ID: 26671081
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B, Zimmy S, Schatz H, Pfohl M.
    Med Klin (Munich); 2003 Feb 15; 98(2):67-71. PubMed ID: 12601530
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. High Titer of Circulating Antiglutamic Acid Decarboxylase Antibodies in a Patient with Cerebellar Ataxia and Type 1 Diabetes.
    Kataria R, Fernandes S, Lebastchi J, Bravo CA, Sena KN.
    Conn Med; 2017 Mar 15; 81(3):161-164. PubMed ID: 29772159
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Autoantibodies associated with autoimmune-mediated cerebellar ataxia].
    Mitoma H, Nanri K.
    Brain Nerve; 2013 Apr 15; 65(4):355-64. PubMed ID: 23568983
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.